We have collected information about Bio-Activated Molecular Delivery Technology for you. Follow the links to find out details on Bio-Activated Molecular Delivery Technology.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411218/
Bio-Activated Molecular Delivery and Multi-Pill Abuse Resistance Technology PharmacoFore, Inc., has developed an abuse-deterrent technology, Bio-Activated Molecular Delivery (Bio-MD), that is aimed at preventing opioid abuse at the molecular level. 45 Unlike most other ADFs, Bio-MD technology is not based on sequestering a drug with a physical ...Author: Robin Moorman-Li, Carol A. Motycka, Lisa D. Inge, Jocelyn Myrand Congdon, Susan Hobson, Brian Pokrop...
https://www.biospace.com/article/releases/pharmacofore-inc-s-bio-activated-molecular-delivery-tm-and-mpar-tm-technologies-to-be-introduced-by-b-dr-lynn-webster-b-at-the-27th-annual-b-/
Mar 28, 2011 · PharmacoFore's technology has the potential to reduce barriers to effective pain management while offering an unprecedented level of resistance to all common routes of abuse." PharmacoFore has created a novel Bio-Activated Molecular Delivery technology designed to effectively deter prescription drug abuse at a molecular level.
https://www.prnewswire.com/news-releases/pharmacofores-bio-activated-molecular-delivery-and-mpar-technologies-to-be-introduced-by-dr-lynn-webster-at-the-27th-annual-american-academy-of-pain-medicine-meeting-118667459.html
PharmacoFore's Bio-Activated Molecular Delivery™ and MPAR™ Technologies to be Introduced by Dr. Lynn Webster at the 27th Annual American Academy of Pain Medicine Meeting
https://www.prnewswire.com/news-releases/pharmacofore-inc-announces-positive-results-from-a-phase-i-clinical-study-of-its-hydromorphone-bio-activated-molecular-delivery-system-and-upcoming-presentation-at-the-2011-bio-business-forum-during-the-annual-bio-internation-124440943.html
Jun 23, 2011 · PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, …
https://www.biospace.com/article/releases/pharmacofore-inc-announces-positive-results-from-a-phase-i-clinical-study-of-its-hydromorphone-bio-activated-molecular-delivery-system-and-upcomin/
Jun 24, 2011 · PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 Biotechnology Industry Organization (BIO) Business Forum During the Annual Bio - read this article along with other careers information, tips and advice on BioSpace
https://egmnblog.wordpress.com/tag/exalgo/
According to the company, the delivery system’s developer, the novel Bio-Activated Molecular Delivery (Bio-MD) technology effectively deters prescription drug abuse at a molecular level. “This technology does not involve the reformulation of existing opioid drugs in physical matrices that are easily circumvented by simple extraction methods.
https://egmnblog.wordpress.com/2011/03/31/drug-makers-go-high-tech-to-prevent-opioid-abuse/
Mar 31, 2011 · According to the company, the delivery system’s developer, the novel Bio-Activated Molecular Delivery (Bio-MD) technology effectively deters prescription drug abuse at a molecular level. “This technology does not involve the reformulation of existing opioid drugs in physical matrices that are easily circumvented by simple extraction methods.
https://www.thefreelibrary.com/New+technologies+address+opioid+abuse%2c+misuse.-a0258242249
May 01, 2011 · According to PharmacoFore, the delivery system's developer, the novel Bio-Activated Molecular Delivery (Bio-MD) technology deters prescription drug abuse at a molecular level. "This technology does not involve the reformulation of existing opioid drugs in physical matrices that are easily circumvented by simple extraction methods.
https://www.ventureradar.com/organisation/Suono%20Bio/d8bbe551-48b4-4467-af37-94f8bf166dce
Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio's platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic.
https://www.future-science.com/doi/10.4155/tde.11.95
Sep 14, 2011 · PharmacoFore, Inc. (San Carlos, CA, USA) announced on 23 June 2011 that positive results had been achieved in a Phase I human proof-of-concept (hPOC) study of its hydromorphone (HM) Bio-Activated Molecular Delivery™ (Bio-MD™) candidate, PF329 [21]. PF329 has been designed using the firm’s Bio-MD technology.Author: Louise Rosenmayr-Templeton
Searching for Bio-Activated Molecular Delivery Technology?
You can just click the links above. The data is collected for you.
